NexThera Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Holding
- Established
- 2020-02-17
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nexthera.org
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
Phase 1
Recruiting
- Conditions
- Wet Age Related Macular DegenerationWet AMD
- Interventions
- Drug: NT-101 0.05 mMDrug: NT-101 0.2 mM
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- NexThera Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06704009
- Locations
- πΊπΈ
Elman Retina Group, Rosedale, Maryland, United States
πΊπΈDuke Eye Center, Durham, North Carolina, United States
πΊπΈErie Retina Research, Erie, Pennsylvania, United States
News
No news found